"The source for European pharmaceutical biotechnology news..."
New Account
RSS

The Magazine

Issue 1

E-magazine

  • Previous Issues

Blog

Where our team of editors discuss what they think about the current NGP US Issues.

Marie Shields
Marie Shields
Editor NGP Europe

Tough competition

The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.
06 Aug 2009
View all White Papers

A bitter pill for generics

No Comments

This article includes a look at ?8+2+1? law; supplementary protection certificate (SPC) regulation; and generic dependence in Central and Eastern Europe.

Disclaimer: All comments posted in a personal capacity
POST A COMMENT
In order to post a comment you need to be regsitered and signed in.
Register | Sign in
No Comments Have Been Submitted
Disclaimer: All comments posted in a personal capacity
In order to post a comment you need to be registered and signed in.
Register | Sign in
NG Pharmaceutical Europe Source: www.ngpharma.eu.com
© 2010 GDS Publishing Ltd. All rights reserved.
Press | About | Contact | Privacy Policy | Sitemap | Subscribe
© 2010 GDS Publishing Ltd. All rights reserved.